133 related articles for article (PubMed ID: 35500878)
1. Combination of serum CST4 and DR-70 contributes to early diagnosis of colorectal cancer.
Cai L; Tu M; Yin X; Zhang S; Zhuang W; Xia Y; Zhang Y; Zhang L; Yu L; Chi L; Huang Y
Clin Chim Acta; 2022 Jun; 531():318-324. PubMed ID: 35500878
[TBL] [Abstract][Full Text] [Related]
2. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
3. Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.
Dou Y; Lv Y; Zhou X; He L; Liu L; Li P; Sun Y; Wang M; Gao M; Wang C
Onco Targets Ther; 2018; 11():1743-1756. PubMed ID: 29636621
[TBL] [Abstract][Full Text] [Related]
4. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
5. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
6. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
8. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
11. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
[TBL] [Abstract][Full Text] [Related]
12. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers.
Liu H; Ye D; Chen A; Tan D; Zhang W; Jiang W; Wang M; Zhang X
Clin Chem Lab Med; 2019 Jun; 57(7):1073-1083. PubMed ID: 30978169
[TBL] [Abstract][Full Text] [Related]
14. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.
Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X
Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262
[TBL] [Abstract][Full Text] [Related]
16. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma.
Ma X; Chen Y; Tang W; Bao H; Mo S; Liu R; Wu S; Bao H; Li Y; Zhang L; Wu X; Cai S; Shao Y; Liu F; Peng J
J Hematol Oncol; 2021 Oct; 14(1):175. PubMed ID: 34702327
[TBL] [Abstract][Full Text] [Related]
17. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
18. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
[TBL] [Abstract][Full Text] [Related]
19. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
20. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
